Roger O'Sullivan
John Balestriere
Eric N. Cohen
Seth Kaufman
November 3rd:
FDA Accepts Arana's Anti-inflammatory IND
September 4th:
Cytopia Commences Second Phase II Study in Brain Cancer
September 4th:
Pharmaxis Announces Second Pivotal Phase 3 Trial in Cystic Fibrosis Begins
August 6th:
Xenome Strengthens Board with Two New Appointments
August 6th:
Ciba Elects to Cease Industrial Product Evaluations
June 24th:
New Pharmaxis Board Appointment
April 29th:
Benitec secures further rights to HIV Therapeutic
April 7th:
Starpharma signs agreement with Unilever
April 1st:
ChemGenex Investigators Present Data on Omacetaxine at International Leukemia Conference
more industry news >
Disclaimer
